[The treatment of blood circulation disorders with an adenosine-theophylline sodium nicotinate combination].
D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D004569:Electroencephalography; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D007871:Leg Ulcer / Q000188:drug therapy*; D008297:Male; D009539:Nicotinic Acids / Q000627:therapeutic use*; D009705:Nucleosides / Q000627:therapeutic use*; D011930:Reaction Time; D013806:Theophylline / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D009539:Nicotinic Acids; D009705:Nucleosides; D014665:Vasodilator Agents; D013806:Theophylline
Die Behandlung von Durchblutungsstörungen mit einer Adenosin-Theophyllin-Natriumnikotinat-Kombination.